Jodi is a senior patent agent in the firm’s Life Sciences and Biotechnology practice group where she focuses on preparing and prosecuting U.S., international, and foreign patent applications. She also counsels clients on other matters relating to patents, including planning and managing patent portfolios and performing patentability analyses.
Jodi’s expertise includes many areas of biotechnology, including virology, immunology, vaccines, oncology, monoclonal antibodies, antibody conjugates, chimeric antigen receptors (CARs) and CAR T cells, cancer immunotherapy, cancer diagnostics, molecular biology, genetics, biochemistry, gene therapy, RNA interference, and antisense technology. Prior to joining Klarquist, Jodi worked as a patent agent for several years at other firms and at a pharmaceutical company, where she managed patent portfolios and prosecuted patent applications in the field of antisense technology. She also previously worked as a post-doctoral research associate at The Scripps Research Institute studying the interaction of adenovirus vectors with the innate immune system and as a post-doctoral research fellow at the Vanderbilt University Medical Center where she studied induction of apoptosis by reovirus, a double-stranded RNA virus.
Jodi joined Klarquist as a patent agent in 2007.